A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates

Mitchell S. Cairo, Avroy A. Fanaroff, R Ellis et al.|The Journal of Pediatrics|1999

Cited by 74